Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
- Zdenek Berger1,
- Hanno Roder1,
- Amanda Hanna1,
- Aaron Carlson1,
- Vijayaraghavan Rangachari1,
- Mei Yue1,
- Zbigniew Wszolek1,
- Karen Ashe2,
- Joshua Knight1,
- Dennis Dickson1,
- Cathy Andorfer1,
- Terrone L. Rosenberry1,
- Jada Lewis1,
- Mike Hutton1, and
- Christopher Janus1
- 1Mayo Clinic Jacksonville, Jacksonville, Florida 32224, and
- 2Department of Neurology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
- Correspondence should be addressed to Mike Hutton, Mayo Clinic Jacksonville, 4500 San Pablo Road, Birdsall Building, Jacksonville, FL 32224. hutton.michael{at}mayo.edu
Abstract
Neurofibrillary tangles (NFTs) are a pathological hallmark of Alzheimer's disease and other tauopathies, but recent studies in a conditional mouse model of tauopathy (rTg4510) have suggested that NFT formation can be dissociated from memory loss and neurodegeneration. This suggests that NFTs are not the major neurotoxic tau species, at least during the early stages of pathogenesis. To identify other neurotoxic tau protein species, we performed biochemical analyses on brain tissues from the rTg4510 mouse model and then correlated the levels of these tau proteins with memory loss. We describe the identification and characterization of two forms of tau multimers (140 and 170 kDa), whose molecular weight suggests an oligomeric aggregate, that accumulate early in the pathogenic cascade in this mouse model. Similar tau multimers were detected in a second mouse model of tauopathy (JNPL3) and in tissue from patients with Alzheimer's disease and FTDP-17 (frontotemporal dementia and parkinsonism linked to chromosome 17). Moreover, levels of the tau multimers correlated consistently with memory loss at various ages in the rTg4510 mouse model. Our findings suggest that accumulation of early-stage aggregated tau species, before the formation of NFT, is associated with the development of functional deficits during the pathogenic progression of tauopathy.
- Copyright © 2007 Society for Neuroscience 0270-6474/07/273650-13$15.00/0





